20 (AIDX) Non-Current Assets (2024 - 2026)

20's (AIDX) quarterly Non-Current Assets came in at $1.1 million in Q1 2026, down 58.63% on a QoQ basis from $2.7 million in Q4 2025.

20 (AIDX) Non-Current Assets (2024 - 2026) Analysis & Trends

20 (AIDX) has 3 years of Non-Current Assets data on file, last reported at $1.1 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Assets (Qtr)
1	Abbott Laboratories	200.51 Bn	194.91 Bn	7.27 Bn	84.70 Bn
2	Stryker	129.96 Bn	126.48 Bn	4.50 Bn	33.51 Bn
3	Medtronic	120.18 Bn	110.96 Bn	6.41 Bn	68.24 Bn
4	Boston Scientific	74.28 Bn	73.74 Bn	3.85 Bn	37.24 Bn
5	Edwards Lifesciences	52.75 Bn	48.50 Bn	1.35 Bn	7.05 Bn
6	Dexcom	34.67 Bn	32.73 Bn	830.00 Mn	2.37 Bn
7	GE HealthCare Technologies	34.23 Bn	32.12 Bn	2.18 Bn	26.75 Bn
8	Koninklijke Philips	26.46 Bn	23.14 Bn	4.55 Bn	20.19 Bn
9	Steris	23.30 Bn	22.82 Bn	684.20 Mn	8.29 Bn
10	20	5.45 Mn	903,174.56	304,727.00	1.05 Mn

Download Data